P ublications. 5.1 Halliburton recognizes that Institution’s Masters students and their academic supervisor(s) may wish to publish some or all of the results of their work on the Program, together with relevant Halliburton information, as a paper within the Recipient’s University or in open literature. At least thirty (30) days prior to any submission for publication, the Recipient shall provide the paper to Halliburton for review, comment, and final approval. Recipient agrees to comply with Halliburton’s comments and requests for changes including but not limited to deleting certain data or information at Halliburton’s sole discretion. This review is not intended to prejudice the scientific interpretation of the results presented, but to ensure appropriate protection of Halliburton Confidential Information and related intellectual property rights. Any resulting materials to be published must be approved in writing by Halliburton prior to submission for publication and shall include the projects assigned mentor as a co-author to the publication. Halliburton reserves the right to retain the copyright ownership of any materials prepared for publication that contain or are derived from Halliburton Confidential Information or Halliburton intellectual property, but will provide the publisher with a non-exclusive perpetual license to re- distribute the copyrighted work to enable publication.
P ublications. UNT shall be free to publish the results of work under this Agreement. Title to and the right to determine the disposition of any copyrights on publications relating to the performance of the work hereunder shall remain with UNT, who shall have the sole right to determine the disposition of those copyrights.
P ublications. The Parties may desire to publish in scientific journals and present at scientific conferences the results of the Collaboration Activities, subject to the following process. Notwithstanding anything to the contrary herein, either Party may propose publication of the results of the Collaboration Activities following scientific review by the JSC (if in force); provided, that no such publication will be made without written approval by Moderna and Merck. After receipt of the proposed publication by both Merck and Moderna, such written approval or disapproval will be provided within [***] days. Both Parties understand that a reasonable commercial strategy may require delay of publication of information or filing of Patent applications, therefore the Parties agree to review and consider delay of publication and filing of patent applications under certain circumstances for a reasonably limited period of time. Once publications have been reviewed by each Party and have been approved for publication, the same publications do not have to be provided again to the other Party for review for a later submission for publication. Expedited reviews for abstracts or poster presentations may be arranged if mutually agreeable to the Parties. Each Party will acknowledge the other Party’s technical, non-financial contributions in any such publication.
P ublications. At least sixty (60) days 8. Z veřejňování. Nejpozději šedesát prior to submitting or presenting a manuscript or other material relating to the Study to a publisher, reviewer or other outside person, Site and/or Investigator will provide to Company and Sponsor a copy of all such material, and allow Company and Sponsor forty-five (45) days to review and comment on them. If requested, Site and/or Investigator will remove any Confidential Information (excluding Study results) before submitting or presenting the materials. Neither party may use the other party’s name, or Sponsor’s name, in connection with any advertising, publication or promotion without the other party’s, or Sponsor’s, prior written permission.
